Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.

MLA

Incerti, Matteo, et al. “Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.” Journal of Medicinal Chemistry, vol. 60, no. 2, Jan. 2017, pp. 787–96. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.6b01642.

APA

Incerti, M., Russo, S., Callegari, D., Pala, D., Giorgio, C., Zanotti, I., Barocelli, E., Vicini, P., Vacondio, F., Rivara, S., Castelli, R., Tognolini, M., & Lodola, A. (2017). Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor. Journal of Medicinal Chemistry, 60(2), 787–796. https://doi.org/10.1021/acs.jmedchem.6b01642

Chicago

Incerti, Matteo, Simonetta Russo, Donatella Callegari, Daniele Pala, Carmine Giorgio, Ilaria Zanotti, Elisabetta Barocelli, et al. 2017. “Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.” Journal of Medicinal Chemistry 60 (2): 787–96. doi:10.1021/acs.jmedchem.6b01642.